While COVID-19 has been associated with elevated PCSK9 levels [19], sLOX-1 and PCSK9 did not correlate in SIRS/sepsis patients after excluding both, patients with liver cirrhosis and those with COVID-19 (r = -0.080, p = 0.385). Here, PCSK9 is linked to cirrhosis of liver.